胸腔内注入尿激酶治疗结核性包裹性胸膜炎临床疗效分析  

Clinical analysis of effects of intrapleural injection of urokinase in the treatment of encapsulated tuberculous pleurisy

作　　者：王华军[1] 王兆华[1] 

机构地区：[1]安徽省蚌埠市传染病医院肺科,233000

出　　处：《淮海医药》2006年第6期465-466,共2页Journal of Huaihai Medicine

摘　　要：目的观察胸腔内注射尿激酶治疗包裹性结核性胸膜炎的疗效。方法在常规治疗下,治疗组76例结核性包裹性胸腔积液患者胸穿抽液后胸腔内注射尿激酶100 000 U,对照组52例不注射。结果治疗组76例,显效61例,有效13例,总有效率97.4%;对照组52例,显效27例,有效14例,总有效率78.8%。结论规则抗痨下,胸内注射尿激酶治疗包裹性结核性胸腔积液可加速胸水的吸收,增加引流量,减轻胸膜增厚度黏连。Objective To observe the treatment effect of injecting urokinase in chest for encapsulated tuberculous pleurisy patients. Methods Regular antituberculosis treatment was given to all patients observed. For the treatment group,urokinase（100, 000 u） was injected into the pleural cavity of 76 patients. For the control group,urokinase was not injected. Results The general effective rate of the treatment group was 97.4%. For the control group it was 78.8%. The effect was significantly different in the two groups. Conclusion For patients with encapsulated tuberculous pleural effusion,regular antituberculosis treatment plus urokinase injection into the pleural cavity can accelerate absorption,increase the drainage,and decrease pleural thickening.

关 键 词：尿激酶 结核性胸膜炎 胸腔注射 

分 类 号：R521.7[医药卫生—内科学]